A real-world analysis of CAR T-cell therapy vs autoSCT in patients with LBCL in complete remission
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-12-18
Просмотров: 75
Описание:
Rémy Duléry, MD, PhD, Saint-Antoine Hospital, Sorbonne University, Paris, France & Dana Farber Cancer Institute, Boston, MA, discusses an extensive real-world analysis comparing the outcomes of patients with large B-cell lymphoma (LBCL) undergoing autologous stem cell transplantation (autoSCT) or CAR T-cell therapy in complete remission (CR). Dr Duléry highlights that survival rates were comparable between groups and discusses the potential implications of these findings. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: